Reporting of Safety Events during Anti-VEGF Treatment: Pharmacovigilance in a Noninterventional Trial

Figure 5

Percentages of adverse events in the MedDRA SOC Eye disorders, over the course of the study. No increase in the proportion of eye disorders was observed over the course of the study. Percentages were calculated based on the total number of events in the respective time period. AE, adverse event; MedDRA, Medical Dictionary for Regulatory Activities; SOC, System Organ Class.